Crossmark Global Holdings Inc. acquired a new position in shares of Shire PLC (NASDAQ:SHPG) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 35,135 shares of the biopharmaceutical company’s stock, valued at approximately $5,381,000.
A number of other institutional investors have also recently made changes to their positions in the business. Inspirion Wealth Advisors LLC raised its position in Shire PLC by 0.4% during the 2nd quarter. Inspirion Wealth Advisors LLC now owns 1,944 shares of the biopharmaceutical company’s stock worth $321,000 after buying an additional 8 shares during the last quarter. Synovus Financial Corp grew its stake in shares of Shire PLC by 0.4% during the 2nd quarter. Synovus Financial Corp now owns 2,780 shares of the biopharmaceutical company’s stock worth $458,000 after purchasing an additional 11 shares during the period. Baldwin Investment Management LLC grew its stake in shares of Shire PLC by 1.4% during the 2nd quarter. Baldwin Investment Management LLC now owns 1,626 shares of the biopharmaceutical company’s stock worth $269,000 after purchasing an additional 23 shares during the period. Hartford Financial Management Inc. grew its stake in shares of Shire PLC by 5.4% during the 2nd quarter. Hartford Financial Management Inc. now owns 621 shares of the biopharmaceutical company’s stock worth $102,000 after purchasing an additional 32 shares during the period. Finally, Lumbard & Kellner LLC grew its stake in shares of Shire PLC by 0.3% during the 2nd quarter. Lumbard & Kellner LLC now owns 18,170 shares of the biopharmaceutical company’s stock worth $3,003,000 after purchasing an additional 55 shares during the period. Institutional investors own 19.27% of the company’s stock.
A number of equities analysts have recently weighed in on the stock. BidaskClub cut shares of Shire PLC from a “sell” rating to a “strong sell” rating in a research note on Wednesday, July 19th. Barclays PLC cut shares of Shire PLC from an “overweight” rating to an “equal weight” rating in a research note on Friday, August 11th. Evercore ISI assumed coverage on shares of Shire PLC in a research note on Wednesday, August 16th. They set an “outperform” rating and a $196.00 price target on the stock. Royal Bank Of Canada reaffirmed a “buy” rating and set a $213.00 price target on shares of Shire PLC in a research note on Monday, October 2nd. Finally, Piper Jaffray Companies set a $159.00 price target on shares of Shire PLC and gave the stock a “hold” rating in a research note on Wednesday, July 26th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and fourteen have issued a buy rating to the company. Shire PLC presently has an average rating of “Buy” and a consensus price target of $211.00.
Shire PLC (NASDAQ:SHPG) last issued its quarterly earnings data on Friday, October 27th. The biopharmaceutical company reported $3.81 earnings per share for the quarter, beating analysts’ consensus estimates of $3.64 by $0.17. Shire PLC had a net margin of 10.95% and a return on equity of 14.41%. The business had revenue of $3.70 billion for the quarter. During the same quarter in the prior year, the firm earned $3.17 earnings per share. Shire PLC’s revenue for the quarter was up 7.1% compared to the same quarter last year.
The business also recently disclosed a semiannual dividend, which was paid on Friday, October 20th. Investors of record on Friday, September 8th were paid a dividend of $0.1527 per share. This represents a dividend yield of 0.21%. The ex-dividend date was Thursday, September 7th. Shire PLC’s dividend payout ratio is currently 17.23%.
COPYRIGHT VIOLATION NOTICE: “Crossmark Global Holdings Inc. Invests $5.38 Million in Shire PLC (SHPG) Stock” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this news story on another domain, it was copied illegally and republished in violation of US and international copyright law. The legal version of this news story can be accessed at https://sportsperspectives.com/2017/11/02/crossmark-global-holdings-inc-invests-5-38-million-in-shire-plc-shpg-stock.html.
Shire PLC Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.